The antibody component, which is 10 times smaller than a full-sized antibody, has been used to make the drug Ab8. Its small size also makes it easy to administer through inhalation. 

The report found the drug has been "highly effective in preventing and treating" SARS-CoV-2 infections in mice and hamsters.